Navigation Links
New Pancreatic Cancer Vaccine Holds Promise

A new vaccine for pancreatic cancer might help increase the life span of people who are suffering from the same. Pancreatic cancer happens to be the fourth leading cause of death from cancer //and is one of the most difficult cancers to treat.

Preliminary results from the cancer vaccine trial show that it improved the survival rates “from an average of about 63 percent one year after diagnosis to 88 percent." It was also found that the percentage of pancreatic cancer patients who survived for two years after diagnosis increased from 42 percent to 76 percent. Lead researcher Daniel Laheru, an assistant professor at the Johns Hopkins Kimmel Cancer Center said in a news release that as of now there is no widely accepted standard to treat pancreatic cancer and surgical removal of the entire area affected by this cancer is the accepted modality. "Even though our results are preliminary, the survival rates are an improvement over most published results of pancreatic cancer treatment studies," he said. The above findings were presented at a cancer meeting in Philadelphia and were arrived at after treating 60 people with pancreatic cancer with the experimental vaccine. The researchers tested out this vaccine after the surgery and postoperative chemotherapy. The vaccine was given 8 to 10 weeks after surgery and four booster doses are recommended after radiation therapy and chemotherapy. Elizabeth Jaffee, MD, of Johns Hopkins Kimmel Cancer Center and the co- researcher in this study said in the press release that follow-up was important, "It is important that we continue to follow these patients to know how the treatment will work in the long term. We're hopeful that these early results will hold true."
'"/>




Page: 1

Related medicine news :

1. Gene Therapy Destroys Pancreatic Cancer Cells
2. Ulcer Surgery connected to danger of Pancreatic Cancer
3. Pancreatic Cancer may be linked to Diabetes
4. Tobacco Found To Trigger Familial Pancreatic Cancer
5. Hope For Those With Pancreatic Cancer
6. Pancreatic cancer risk
7. High-Vegetable & Fruit Diet Reduce The Risk Of Pancreatic Cancer
8. Intake Of Processed Meat And Fat Associated With Pancreatic Cancer
9. New Treatment Found For Pancreatic Cancer
10. Vegetable Rich Diet Can Cut Risk Of Pancreatic Cancer
11. Pancreatic Cancer Surgery Successful in 80-Year-Olds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: